Meglumine

Chemical formula: C₇H₁₈NO₈Sb  Molecular mass: 365.98 g/mol 

Active ingredient description

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
P01CB01 Meglumine antimonate P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01C Agents against leishmaniasis and trypanosomiasis → P01CB Antimony compounds
Discover more medicines within P01CB01

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 133-51-7
DrugBank Drug: DB13732
RxNorm Ingredient: 319866
UNII Identifier: 6HG8UB2MUY
MEGLUMINE
UNII Identifier: 75G4TW236W
MEGLUMINE ANTIMONIATE

Medicines

Meglumine is an active ingredient of these brands:

United States (US)

Brazil (BR)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Finland (FI)

France (FR)

Hong Kong (HK)

Ireland (IE)

Japan (JP)

Malta (MT)

New Zealand (NZ)

Poland (PL)

Singapore (SG)

Spain (ES)

Tunisia (TN)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.